D-0550-2026 Class III Ongoing
FDA drug recall D-0550-2026 was initiated by AVEVA Drug Delivery Systems, Inc. on May 14, 2026 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units. The recall status is ongoing. Affected quantity: 59,808 pouches (4,272 Individual Folding Carton (IFC)).
Recall details
- Product Type
- Drugs
- Report Date
- Jun 3, 2026
- Initiation Date
- May 14, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 59,808 pouches (4,272 Individual Folding Carton (IFC))
Product description
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.
Reason for recall
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
Distribution pattern
Nationwide within the U.S
Code information
Lot #: 56841, Expires: 03/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0550-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026